Status:
COMPLETED
Clinical Trial Examining Effects of Monosodium Glutamate (MSG) on Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
University of Arizona
Conditions:
Irritable Bowel Syndrome
Fibromyalgia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Objective: Randomized, double blind, placebo-controlled, crossover, clinical trial to examine the effects of the food additive glutamate (in the form of MSG) on IBS and fibromyalgia. Setting and Subj...
Eligibility Criteria
Inclusion
- Men and women aged 18-75 who fulfill criteria for Irritable Bowel Syndrome (IBS) and Fibromyalgia (FM)
- They must live in the greater Portland, OR, metro area, have transportation to/from study site, have access to email
- Willing to discontinue medications with bowel altering side effects
Exclusion
- Asthma
- Inflammatory bowel disease
- Colon cancer or active endometriosis
- Any major abdominal surgery (excluding caesarean section, tubal ligation, hernia repair, gall bladder removal or appendectomy)
- Female and pregnant
- Currently taking pregabalin, gabapentin, or anti-psychotic medications and are unwilling/ unable to discontinue use
- Suffered from alcohol/substance abuse or psychosis in the last two years.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00829218
Start Date
January 1 2009
End Date
May 1 2010
Last Update
December 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health & Science University
Portland, Oregon, United States, 97238